Best’s Review® Releases Digital Supplement on Captive Insurers

OLDWICK, N.J.--(BUSINESS WIRE)-- Best's Review magazine has released a new online supplement­­­ that explores the expansion of captive insurers around the globe. Read now.

The supplement features stories on:

• Proposed changes to the Alternative Risk Transfer ratings criteria.
• How many single-parent captives are being repurposed for broader risks.
• How captives can be an efficient choice for enterprise risk management in hard markets.
• The flexibility and low capital needs of cell captives.

In addition to providing expert insight from industry leaders around the globe, the supplement includes a ranking of the largest published, rated single-parent captive insurers in 2025. Information for the ranking is drawn from AM Best's BestLink® database, a powerful online platform that provides access to Best's Insurance Reports®, Best's Financial Suite and Best’s Alert Service.

Insurance associations and businesses related to or serving the captive industry can reach this audience by advertising in this supplement. Space is still available for those interested in appearing alongside expert coverage on captive insurers, or in any of our future digital supplements. To learn more, visit our 2025 advertising media kit or contact the advertising sales team at [email protected] or +1 908 882 1706.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2025 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250305470529/en/

Lee McDonald
Senior Vice President, Publication & News Services
+1 908 882 2102
[email protected]

Source: AM Best

You May Also Be Interested In

• Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
• Zum Appoints Matthew Klein as VP of Software Sales
• Sixty-Six Capital Expands Effective Bitcoin Exposure with Option for up to 200 BTC and Move to Direct Holdings